Davis Polk advised Clarivate Science Holdings Corporation on the offering. Clarivate Science Holdings Corporation, an indirect wholly-owned subsidiary of Clarivate Plc, executed a Rule 144A / Regulation S offering of $1 billion…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
